Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.

[1]  D. Spyker,et al.  Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction , 1983, Antimicrobial Agents and Chemotherapy.

[2]  E. Burgess,et al.  Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis , 1983, Antimicrobial Agents and Chemotherapy.

[3]  J. Humphries,et al.  Peritonitis in continuous ambulatory peritoneal dialysis patients. , 1983, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  M. Brier,et al.  Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis , 1983, Clinical pharmacology and therapeutics.

[5]  P. Somani,et al.  Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis , 1982, Clinical pharmacology and therapeutics.

[6]  E. Swabb,et al.  Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects , 1982, Antimicrobial Agents and Chemotherapy.

[7]  T. Golper,et al.  Stability of antimicrobial agents in peritoneal dialysate , 1982, Antimicrobial Agents and Chemotherapy.

[8]  G. Bodey,et al.  Comparative in vitro study of SQ26,776 , 1982, Antimicrobial Agents and Chemotherapy.

[9]  K. Bush,et al.  Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria , 1982, Antimicrobial Agents and Chemotherapy.

[10]  K. Iseki,et al.  Captopril (SQ 14225) clearance during hemodialysis treatment. , 1981, Clinical nephrology.

[11]  O. Cars,et al.  A microtechnique for the determination of antibiotics in muscle. , 1981, The Journal of antimicrobial chemotherapy.

[12]  M. Sussman,et al.  Pharmacokinetics of intravenous and intraperitoneal cefuroxime in patients undergoing peritoneal dialysis. , 1981, Clinical nephrology.

[13]  F. Luft,et al.  Moxalactam pharmacokinetics during hemodialysis , 1981, Antimicrobial Agents and Chemotherapy.

[14]  C. Comty,et al.  Pharmacokinetics of gentamicin in patients undergoing continuous ambulatory peritoneal dialysis , 1981, Antimicrobial Agents and Chemotherapy.

[15]  P. J. Wills,et al.  Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease , 1981, Antimicrobial Agents and Chemotherapy.

[16]  J. Bower,et al.  Peritoneal dialysis during peritonitis. , 1981, Kidney international.

[17]  B. Meyers,et al.  Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis , 1981, Antimicrobial Agents and Chemotherapy.

[18]  R. Ogilvie,et al.  Cefoxitin disposition during peritoneal dialysis , 1981, Antimicrobial Agents and Chemotherapy.

[19]  J. S. Wells,et al.  Monobactams—monocyclic β -lactam antibiotics produced by bacteria , 1981 .

[20]  E. Swabb,et al.  Pharmacokinetics of the monobactam SQ 26,776 after single intravenous doses in healthy subjects. , 1981, The Journal of antimicrobial chemotherapy.

[21]  J. S. Wells,et al.  Monobactams--monocyclic beta-lactam antibiotics produced by bacteria. , 1981, The Journal of antimicrobial chemotherapy.

[22]  R. Wise,et al.  SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents. , 1981, The Journal of antimicrobial chemotherapy.

[23]  D. Perrier,et al.  Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyzability , 1978, Clinical pharmacology and therapeutics.

[24]  V. Andriole.  Pharmacokinetics of cephalosporins in patients with normal or reduced renal function. , 1978, The Journal of infectious diseases.

[25]  J. Fillastre,et al.  Pharmacokinetics of cefoxitin sodium in normal subjects and in uraemic patients. , 1978, The Journal of antimicrobial chemotherapy.

[26]  H. Imanaka,et al.  NOCARDICIN A, A NEW MONOCYCLIC β-LACTAM ANTIBIOTIC , 1976 .

[27]  J. Anderson,et al.  Letter: Brittle diabetes. , 1974, Lancet.